If You Invested $1000 in Veeva Systems a Decade Ago, This is How Much It'd Be Worth Now

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries.The fear of missing out, or FOMO, also plays a factor in investing, especially with particular tech giants, as well as popular consumer-facing stocks.What if you'd invested in Veeva Systems (VEEV) ten years ago? It may not have been easy to hold on to VEEV for all that time, but if you did, how much would your investment be worth today?Veeva Systems' Business In-DepthWith that in mind, let's take a look at Veeva Systems' main business drivers. Headquartered in Pleasanton, CA, Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company’s product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data).Veeva CRM is the company’s flagship product and runs on salesforce.com’s SaaS platform. The contract between Veeva and salesforce.com extends till 2025. In May 2023, Veeva unveiled Vault CRM, built on the Veeva Vault Platform. It has the full functionality of Veeva CRM and significant new innovations, including two new applications CRM Bot and Service Center.Veeva Systems has also released its advanced Veeva Commercial Cloud offering, Veeva CRM Engage Webinar, at the Veeva Commercial Summit Europe. Veeva Systems also released Veeva Vault PromoMats Brand Portal — a new digital asset management capability that helps brand managers create portals, organize and showcase content within Veeva Vault PromoMats.Veeva Systems has also announced the availability of the whole suite of commercial data products from Veeva Compass Suite for a more comprehensive understanding of patient groups and HCP-level information.FY25 at a GlanceFor fiscal 2025, VEEV registered total sales of $2.75 billion, up 16% year over year. VEEV reported adjusted earnings per share of $6.60 for fiscal 2025, up 36.4% compared with fiscal 2024.Subscription Service revenues were $2.28 billion (83.2% of net sales, up 20% from fiscal 2024), while Professional services and other revenues grossed $461.9 million (16.8%, down 0.03%).Bottom LinePutting together a successful investment portfolio takes a combination of research, patience, and a little bit of risk. For Veeva Systems, if you bought shares a decade ago, you're likely feeling really good about your investment today.According to our calculations, a $1000 investment made in June 2015 would be worth $10,427.40, or a gain of 942.74%, as of June 23, 2025, and this return excludes dividends but includes price increases.The S&P 500 rose 182.84% and the price of gold increased 174.72% over the same time frame in comparison.Looking ahead, analysts are expecting more upside for VEEV. Veeva Systems stands out as a long-term winner in life sciences digitalization, thanks to strong execution, deep customer relationships, and an expanding product portfolio. Vault CRM is gaining real traction with over 80 customers live, including top 20 pharma, while data-driven tools like Crossix and Compass are delivering high ROI. Per the Zacks Model, total revenues and adjusted EPS are projected to grow at a CAGR of 16.3% and 23.6% from fiscal 2023 to 2027. With a $6 billion cash cushion, consistent R&D investment, and domain-specific AI tools launching in December, Veeva is well-positioned for sustainable growth. While macro pressures and small biotech funding risks remain, Veeva’s platform depth and mission-critical value create strong long-term upside. Hence, we reiterate our Outperform recommendation. The stock has jumped 20.21% over the past four weeks. Additionally, no earnings estimate has gone lower in the past two months, compared to 10 higher, for fiscal 2025; the consensus estimate has moved up as well.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Veeva Systems Inc. (VEEV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks